BIOLASE, INC Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Biolase, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Biolase, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$721K, a 17.8% increase year-over-year.
  • Biolase, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$2.48M, a 33.7% increase year-over-year.
  • Biolase, Inc annual Nonoperating Income (Expense) for 2023 was -$2.66M, a 16.4% increase from 2022.
  • Biolase, Inc annual Nonoperating Income (Expense) for 2022 was -$3.19M, a 1043% decline from 2021.
  • Biolase, Inc annual Nonoperating Income (Expense) for 2021 was $338K, a 81.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.48M -$721K +$156K +17.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$2.64M $442K +$1.41M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$4.05M -$1.94M -$1.38M -248% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$2.66M -$265K +$1.08M +80.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$3.75M -$877K -$124K -16.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$3.62M -$965K -$432K -81.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$3.19M -$557K -$4K -0.72% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$3.19M -$1.35M -$569K -73% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$2.62M -$753K -$148K -24.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$2.47M -$533K -$3.03M -121% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $564K -$553K +$226K +29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $338K -$779K +$2.42M +75.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-21
Q3 2021 -$2.08M -$605K -$4.3M -116% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.22M $2.5M +$1.84M +276% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $383K -$779K -$1.45M -216% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.84M -$3.2M -$7.1M -182% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 $8.94M $3.69M +$4.26M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.67M $665K +$1.2M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $3.47M $673K +$1.19M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.28M $3.9M +$4.34M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 -$2.06M -$570K -$464K -438% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$1.6M -$534K -$312K -141% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$1.28M -$521K -$716K -367% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$568K -$435K -$621K -334% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-31
Q3 2018 $53K -$106K -$290K -158% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $343K -$222K -$449K -198% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $792K $195K +$187K +2338% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $605K $186K +$465K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-30
Q3 2017 $140K $184K +$142K +338% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$2K $227K +$336K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$338K $8K -$80K -90.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 -$258K -$279K -$147K -111% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-08
Q3 2016 -$111K $42K -$11K -20.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 -$100K -$109K -$133K -554% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $33K $88K +$218K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$185K -$132K +$123K +48.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$308K $53K +$225K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$533K $24K +$242K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 -$775K -$130K +$98K +43% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$873K -$255K -$65K -34.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 -$808K -$172K -$6K -3.61% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$802K -$218K -$110K -102% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$692K -$228K -$42K -22.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q4 2013 -$650K -$190K -$53K -38.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 -$597K -$166K -$40K -31.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 -$557K -$108K +$22K +16.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$579K -$186K -$165K -786% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$414K -$137K -$60K -77.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-06
Q3 2012 -$354K -$126K -$168K -400% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$186K -$130K -$108K -491% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$78K -$21K +$315K +93.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$393K -$77K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 $42K +$316K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$22K +$7K +24.1% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-06
Q1 2011 -$336K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$274K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$29K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.